Gene transfer of the herpes simplex virus thymidine kinase ( HSV -tk ) gene sensitizes tumor cells to the toxic effect of ganciclovir ( GCV ) . The toxic effect of GCV extends to nontransduced surrounding cells by a metabolic process known as the bystander effect. A distant bystander effect, which involves anatomically separated tumors, has been reported in vivo. Our aim was to evaluate and characterize such distant effect in a rat model of colorectal tumors implanted in the liver using adenovirus to carry the HSV -tk gene. Two colorectal tumors were implanted in two distinct liver lobes of the liver. One of the tumor was transduced with an adenoviral vector containing HSV -tk gene. The volumes of the tumors were monitored after GCV treatment. Implication of the immune system was studied histologically and after in vivo manipulations. After GCV administration, the nontransduced distant tumor regressed partially or completely in the experimental group. Immunohistochemical analysis revealed the presence of CD8 + lymphocytes in the distant lesion. HSV -tk / GCV ± induced immune response against tumors was evidenced by an adoptive transfer assay ( Winn assay ) and the distant bystander effect was blunted after CD8 + lymphocytes depletion. However, the survival rates for treated animals were not improved. These findings demonstrate that an immune -mediated effective distant bystander effect can be obtained after limited adenoviral -mediated transfer of the HSV -tk gene. Cancer Gene Therapy ( 2001 ) 1 This gene encodes a protein that phosphorylates ganciclovir (GCV ) , an innocuous nucleoside analog, into a monophosphate form. This latter is a substrate for eukaryotic kinases and is subsequently transformed in GCV di -and triphosphate. GCV triphosphate is able to incorporate into replicating DNA strands, causing chain termination and subsequently cell death via apoptosis. Moreover, it has been demonstrated that after HSV-tk gene transfer followed by GCV treatment, cell death extended beyond the HSV-tk ± expressing cells and that HSV-tk ± negative surrounding cells were also destroyed after GCV exposure.
T he herpes simplex virus thymidine kinase (HSV-tk ) gene has emerged as the most widely used so -called`s uicide'' gene in both experimental studies and clinical protocols of cancer gene therapy. 1 This gene encodes a protein that phosphorylates ganciclovir (GCV ) , an innocuous nucleoside analog, into a monophosphate form. This latter is a substrate for eukaryotic kinases and is subsequently transformed in GCV di -and triphosphate. GCV triphosphate is able to incorporate into replicating DNA strands, causing chain termination and subsequently cell death via apoptosis. Moreover, it has been demonstrated that after HSV-tk gene transfer followed by GCV treatment, cell death extended beyond the HSV-tk ± expressing cells and that HSV-tk ± negative surrounding cells were also destroyed after GCV exposure. 2 This phenomenon is now referred to as the bystander effect and dramatically amplifies the suicide gene effect to such an extent that HSV-tk gene transfer in vitro in as few as 10% of cultured cells triggers, in the presence of GCV, death of the whole population. The bystander effect is mediated by intercellular diffusion of the toxic phosphorylated compounds via gap junctions and is missing in cells lacking connexins, the structural component of gap junctions. 3, 4 Although this effect is predominantly observed in vitro in cultured cells, it has been suggested that it may also exist in vivo. Because connexins are involved in gap junctions, it is hypothesized that the bystander effect will only be effective in vivo when normal connexin gene expression is conserved and the protein remains functional. In vivo studies have also implicated the potential role of the immune system in the development of a bystander effect as well as in the long -term induction of immune response against the tumor cells after treatment with HSV-tk and GCV. 5 ± 8 Similarly, an immune -related antitumor response has been proposed to explain the``distant'' bystander effect observed in vivo when tumors are located far apart with no possible metabolic cooperation between cells. 9, 10 However, conflicting results have been reported in which the occurrence of a distant bystander effect in immunodeficient animals was described. 11, 12 Recently, Kianmanesh et al 9 described the use of an elegant model to study the distant bystander effect in experimental rat colon carcinoma metastases using an HSV-tk retroviral vector. However, they were not able to completely eradicate distant nontransduced tumors. The aim of the present study was to evaluate the existence of a distant bystander effect in a rat model of hepatic metastasis of colon carcinoma using a HSV-tk adenoviral vector. This model allows the establish-ment and follow -up of the initial and secondary distant tumors that can be monitored precisely. HSV-tk gene was delivered in situ using an E1 -deleted adenoviral vector to one tumor implanted in one liver lobe, and we subsequently monitored the distant tumor implanted in a distinct hepatic lobe and characterized the antitumoral immune response upon GCV administration.
MATERIALS AND METHODS

Animals
Six -to eight -week -old male, syngeneic BDIX rats were obtained from Iffa-Credo (L'arbresle, France ) . They were housed one to five in each box and received food and water ad libitum. All experiments were carried out according to the guidelines of the French Ministe Áre de l'Agriculture.
Cell lines
PROb cells are derived from dimethylhydralazine chemically induced BDIX rat colon DHDK12 carcinoma cell line. PROb cells are part of the DHDK12 variant cell line which is resistant to trypsin and consistently engraft and produce tumors in BDIX rat. 13 
Culture conditions
Cells were cultured using RPMI 1640 medium, supplemented with 10% fetal calf serum ( FCS ), L -glutamine, and antibiotics ( Streptomycin 100 g /mL +Penicillin 100 UI / mL ) at 378C in a 5% CO 2 atmosphere. The absence of mycoplasma contamination is routinely checked in our laboratory.
Adenoviral vector
Human type -5 recombinant E1 -deleted adenoviruses were prepared using standard protocols in the 293 cell lines. Adtk vector contains the HSV-tk gene under the transcriptional control of the RSV ( Rous Sarcoma Virus ) promoter. Control Ad -lacZ vector harbours the Escherichia coli beta galactosidase gene coupled to a nuclear localization signal and under control of the same RSV promoter. The titer of the viral preparations was 10 11 pfu (plaque -forming unit ) / mL. Viral preparations were stored at À 808C in 10% glycerol until used. Lack of detectable wild -type Ad contaminant was confirmed by PCR using primers specific for the E1 region.
Tumor implantation and Ad -tk injection
At 70% confluence, PROb cells were rinsed in EDTA 10 mM, trypsinized, and resuspended in RPMI medium without FCS at a concentration of 1Â10 6 PROb cells in 100 L. Syngeneic BDIX rats were anesthesized with ketamine ( 50 mg / mL) and xylazine ( 20 mg /mL) intraperitoneally ( i.p. ) . Rats underwent a laparotomy, and medial and lateral lobes of the liver were exposed. PROb cells were injected in 100 L under the liver capsule. To limit the spreading of the cells in the peritoneal cavity, the syringe was taken out slowly after injection and a saline rinse was systematically performed. Hemostatic compress was applied at the point of injection when needed before closure of the abdominal wall. Every rat had a PROb cells injection in the right part of the medial lobe ( tumor A ) on day 0 of the experimentation. On day 7, a second tumor ( tumor B ) was implanted in the left lateral lobe using the same procedure. Both tumors were anatomically far apart from each other. On day 9, rats were anesthesized and laparotomized to expose the medial lobe. Tumor A was located and 20 L of the Ad -tk preparation was directly injected into the tumor. Control animals received the same amount of Ad -lacZ.
GCV treatment protocol
GCV sodium lyophilisate ( Roche, France) was dissolved in NaCl 0.9% at a final concentration of 2 mM and kept at 48C for 7 days after reconstitution. One milliliter of the drug was administered intraperitoneally, corresponding to a dose of 75 mg /kg of body weight, every 12 hours for 5 days. The first injection was performed on day 10 of the experiment (as shown in Fig 1) . Control animals received saline i.p., instead, every 12 hours for 5 days.
Tumor evaluation
To assess tumor progression or remission, a liver magnetic resonance imaging (MRI ) evaluation was performed. MRI was performed with an imager 1.5 T using spin -echo T2 weighted sequences. To increase the contrast between tumor and normal adjacent parenchyma, animals received an intravenous injection of ultra small superparamagnetic iron oxide particles ( AMI -HS 10 mM /kg; Guerbet, France ). When animals were sacrificed, each hepatic tumor was excised and some of them were carefully measured to determine the three diameters in mm ( a, b, c ). We used the Detlevsen's formula to estimate the volume of the tumor ( V= /6abc, mm 3 ). Areas where liver tumors had been implanted were dissected out for histologic analysis. The presence of peritoneal carcinosis was also systematically evaluated by careful examination of the peritoneal cavity for the presence of tumor nodules.
Survival assay
For each animal, we noted the date of the death and the presence of peritoneal carcinomatosis, ascites, or pulmonary metastases. A standard survival curve was drawn and statistical analysis was made using the log -rank (MantelCox ) test. A P value <.05 was considered to indicate a significant difference between groups.
Standard histology and immunohistochemical studies
Ad -tk ± transduced tumors (tumor A ) were easily located and were sectioned in two fragments. The first one was fixed in 10% formaldehyde before paraffin embedding. The 5-m -thick sections were stained with hematoxylin ± phloxin ± saffron. The second fragment was embedded in OCT compound and snap -frozen in liquid nitrogen ± cooled isopentane. In some experimental animals, tumor B was sometimes difficult to locate. The area where tumor B was implanted was excised and processed in a similar manner.
Cryostat sections (5 m ) from frozen samples were fixed for 5 minutes at room temperature in cold acetone. Blocking of endogenous peroxidase activity was achieved after a 20-minute incubation in 0.3% H 2 O 2 in methanol. Sections were successively incubated for 20 minutes in 3% bovine serum albumin and with primary antibodies diluted in 0.1% bovine serum albumin for 12 hours at 48C. After washing in phosphate -buffered saline, sections were incubated for 30 minutes at room temperature with biotinylated secondary antimouse immunoglobulin. Staining was performed using the avidin± peroxidase method. We used the following antibodies at the indicated dilutions: R7.3 (anti -TCR ; 1:500 ), OX38 ( anti -CD4; 1:10 ), OX8 ( anti -CD8; 1:10 ) , OX33 (anti -CD45; 1:500 ), kindly obtained from Marc Gre Âgoire. E3.2.3 ( anti -NK; 1:500 ) was a gift from Ignacio Anegon. Immunodetection of macrophages using the ED1 antibody ( kind gift from Ignacio Anegon ) was carried out on paraffin sections using the same protocol after dewaxing in toluene and rehydration in ethanol.
Winn assay
Five rats were subjected to tumor implantation and Ad -tk gene transfer as described above. On day 9, rats were either treated with GCV (rats GCV + ; n= 3) or received saline, instead (rats GCV À; n = 2) . On day 18, all rats were killed, spleens were removed, and splenocytes were harvested on a Ficoll gradient. Splenocytes ( 10 8 cells) were then mixed with 2.10 6 PROb cells in 0.5 mL of RPMI. The mixture was then injected subcutaneously in the superior and external part of the right leg in 15 naive BDIX rats. These animals were divided in three groups: group 1 ( n =5 ) received 0.5 mL containing 10 8 splenocytes (GCV + ) mixed with 2.10 6 PROb cells; group 2 ( n =5 ) received 0.5 mL containing 10 8 control splenocytes (GCV À ) mixed with 2.10 6 PROb cells; group 3 (n =5 ) received 0.5 mL containing 2.10 6 PROb cells only. Tumors were then measured, blindly with a caliper, weekly for 10 weeks. Tumor volumes were calculated using the Detlevsen's formula ( V= abc/ 6, where a, b, and c are the three larger diameters of the tumor ). On day 70, animals were sacrificed, subcutaneous tumors were excised, measured, and weighed.
Depletion assay
The antibody OX8 (anti -CD8 ) was obtained from a hybridoma culture supernatant. Six rats were treated following the protocol shown in Figure 1 . Three of 6 rats received the OX8 antibody at 2 mg /mL. A 400 -L OX8 i.p. injection was performed once a week until the sacrifice (first injection on day 5 of the protocol ) . To confirm the immune depletion, we evaluated by FACS analysis the proportion of circulating CD8 + lymphocytes on a blood sample of the three depleted rats and one control animal. The volume of the tumors in the depleted group was evaluated on day 15 by MRI. All animals were killed on day 23 except two depleted rats that died on day 19 from unknown reasons. The volume of the tumors was measured in all animals and the samples were then used for histology.
RESULTS
In vivo evaluation of the distant bystander effect
The protocol for ProB cell implantation and subsequent injection of the adenoviral vector followed by GCV treatment is summarized in Figure 1 . In each rat, two tumors ( A and B ) were implanted in two separate liver lobes. Tumor A was implanted on day 0 and tumor B on day 7. Tumor A was injected on day 9 with 2Â10 9 pfu of an E1 -deleted HSV-tk adenoviral vector ( Ad -tk ) . After injection, the rats were divided in two groups: animals from the GCV-treated group (n = 26) received GCV i.p. for 5 days starting on day 10, and animals from the saline group ( n =17 ) received saline i.p. Additional control animals received control AdlacZ vector alone ( n =3 ), Ad -lacZ and GCV ( n =3 ), and GCV alone ( n= 3) . Rats were sacrificed between days 20 and 24 except when respective time course analysis of the distant bystander effect was monitored.
A liver MRI was performed in 14 GCV-treated, 11 salinetreated, as well as three Ad -lacZ ± injected animals to monitor the development of the tumors. MRI was performed weekly (days 10, 18, and 24) . On day 10 of the experiment ( i.e., immediately before GCV administration; see Fig 1a ) , A tumors were visible in all rats but the majority of B tumors
were not yet detected in both groups. This is probably related to the small size of tumor B at that time because the resolution of our MRI imaging was estimated to be around 3 mm. In one case, we were able to detect the presence of both tumors on the same MRI section ( Fig 2 ) . On day 15 ( i.e., at the end of the GCV treatment) , both A and B tumors were clearly identified in saline -treated, as well as in Ad -lacZ ± injected, animals whereas the majority of GCV-treated rats had only tumor A visible. On day 24, only tumor A remained visible in all GCV-treated rats. At that time, both A and B tumors were consistently observed in saline -treated, as well as in Ad -lacZ ± injected, animals although on different MRI sections.
A time course analysis was performed in a subgroup of 14 Ad -tk ± injected rats ( seven in the GCV-treated group and seven in the saline-treated group ) . Animals were sacrificed on different time points (days 17, 20, 24, 28, 31, 35, 38, with one rat of each group at each indicated time point ). Figure 3 represents the tumor volumes measured at the time of necropsy. We found that A tumors of each group had comparable volumes (Fig 3A ) . On the contrary, important differences appeared in the volume of B tumors. The seven saline -treated animals had voluminous B tumors, whereas four GCV-treated rats had no detectable tumor B and two animals had significantly smaller tumor B. In one case, the tumor B was as large as in the saline -treated group ( Fig 3B) . We also noticed that a distant bystander effect with complete regression of tumor B could still be observed on day 38.
At necropsy, macroscopic tumor analysis in all rats subjected to the protocol revealed that A tumors had similar volume in all control, as well as treated, animals. All rats of control groups (including animals injected with Ad -lacZ or receiving GCV alone ) had voluminous B tumors indicating that neither GCV alone nor Ad -lacZ was able to trigger a (Fig 4) . On the opposite, the volume of B tumors in the GCV-treated group was consistently smaller, demonstrating the existence of a distant bystander effect. In 12 rats (46%), the distant bystander effect resulted in a complete histological regression of tumor B. In five rats among these 12 treated rats, no remnant trace of the implanted tumor was found. In those animals, we only observed a local thickening of the hepatic capsule. For the remaining seven complete responders, the precise site of tumor B implantation was spotted, lacking neoplastic cells but containing some fibroblastic cells in a fibrotic area mostly surrounded by an inflammatory infiltrate ( Fig 5 ) . In the latter, mononuclear cells were predominant, without macrophage infiltration. Besides the 12 complete responders, we found in six GCV-treated animals ( 23% ) histological evidence for an almost complete regression of tumor B, but with remaining neoplastic cells within the fibrotic and inflammatory lesion. Six other rats of the GCVtreated group ( 23% ) displayed a partial tumoral regression, but tumor B was clearly delimited. Finally, only two rats of the GCV-treated group (8% ) had voluminous B tumors, similar to those of the control saline-injected group. Therefore, a total of 92% GCV-treated rats exhibited a distant bystander effect. We also systematically looked for the presence of peritoneal carcinomatosis and found that its occurrence was reduced in GCV-treated group as compared to the saline -treated animals. Peritoneal carcinomatosis was present in 11 of 17 saline -treated rats (65% ), whereas only 3 of 26 treated rats had a macroscopic detectable carcinosis ( 12% ) .
Immunohistochemistry
To document the implication of the immune system in the development of a distant bystander effect in our model, we characterized the various cell types present in the infiltrate surrounding the regressive tumors. The periphery of the regressive tumors, as well as the fibrotic areas found in responders, contained cells of the lymphocytic lineage. In this group, portal inflammation was intense and peritumoral inflammation revealed numerous T lymphocytes staining positive with the anti -CD8 antibody (Fig 6) . The specificity of our antibody was routinely checked on spleen sections and no staining was apparent when primary antibody was omitted ( not shown) . CD8 + cells were located around and also inside tumor B and the number of CD8 + cells was more prominent in rats sacrificed earlier in the protocol. CD4 + cells were rarely observed in the fibrotic areas. Natural killer cells were rare and, when present, gathered in the periportal inflammation. B lymphocytes were absent and there was no evidence of macrophage infiltration ( Fig 6 ) .
Survival rate assay
We next asked whether the development of a bystander effect could protect the animals from premature carcinomatosisinduced death. A survival rate assay was performed with 15 additional rats which were subjected to the complete protocol (see Fig 1 ) . After tumor implantation and Ad -tk injection, GCV was then administered in eight animals from days 10 to 15, whereas seven received saline i.p. Experimental and control animals died between days 65 and 108 and we found no significant difference in the survival rate between the two groups (Fig 7 ) . At necropsy, in five of eight rats in the GCV-treated group, we could not conclude for the existence of a distant bystander effect because tumor B was voluminous. In the remaining three rats, we found small tumors and even in one of them, on day 97, tumor B was not macroscopically detectable. However, histologic examination of the latter revealed the presence of tumor cells. These observations suggested that a distant bystander effect had occurred, although it did not significantly improve the survival rate. Importantly, we found numerous pulmonary metastases in all animals in both groups, suggesting that death might have been related to cancer progression in extrahepatic organs.
Winn assay
To further explore the role of the immune system in the establishment of a distant bystander effect, we performed an in vivo Winn assay as described in Materials and Methods. Briefly, 15 rats were divided in three equal groups and were injected subcutaneously with PROb cells and splenocytes isolated from GCV-treated rats ( group 1) ; PROb cells and splenocytes from saline-injected rats ( group 2) ; and PROb cells only ( group 3) . Tumor volumes were monitored weekly in all animals for 10 weeks. As shown in Figure 8 , tumors in groups 3 and 2 grew exponentially and similarly. In contrast, tumors in group 1 grew slower and were significantly smaller. Moreover, we also found that the final weight of subcutaneous tumors on day 70 was similar in groups 2 and 3 ( 9.84 2.38 and 8.94 1.23 g, respectively ) and was lower in group 1 (5.62 1.59 g) . Finally, skin fistulization of the tumor was observed in four of five and three of five animals in groups 2 and 3, respectively, and only one of five rats in group 3.
Depletion assay
To confirm the involvement of CD8 + lymphocytes in the bystander effect, three rats were immunodepleted by weekly i.p. administration of a purified anti -CD8 antibody until rats were sacrificed. Immunosuppression was checked by FACS analysis of a blood specimen on day 15 after the anti -CD8 antibody injections. CD8 depletion in all rats ranged from 84% to 99% (data not shown ). The three CD8 -depleted rats and three nondepleted control animals were subjected to tumor implantation in the liver followed by Ad -tk injection and GCV treatment as described in Figure 1 . Animals were sacrificed on day 23 of the experiment at a time when the distant bystander effect is optimal. In the control nondepleted, GCV-treated animals, necropsy revealed the presence of tumor A measuring 28, 38, and 33 mm 3 and, as expected, no tumor B was macroscopically detected in all three animals. Instead, a fibrotic scare was seen, testifying the site of PROb injection. On the opposite ( Fig 9 ) , tumor B was present in all CD8 -depleted animals, supporting the implication of CD8 + lymphocytes in the development of a distant bystander effect in this model. Two of the CD8 -depleted rats died prematurely on day 19 from unknown reason, but both tumors were easily located, measuring 65 and 42 mm 3 . The third depleted rat was sacrificed on day 23 and had a 44 -mm 3 tumor A and a 25 -mm 3 tumor B.
DISCUSSION
In the present report, we have studied in a large group of animals ( n= 52) the occurrence of a distant bystander effect after adenoviral -mediated HSV-tk gene transfer and GCV administration in a model of metastatic colon carcinoma tumors implanted in two distinct liver lobes. After injection of Ad -tk in a single tumor, GCV treatment led to a dramatic antitumoral effect in a distant, nontransduced, implanted tumor. The anatomical distance between both tumors excluded a local bystander effect mediated by GCV-related metabolic cooperation between adjacent cells. Interestingly, we demonstrated that a distant bystander effect could lead to complete regression to scars of the untransduced tumor in 46% of the animals. Overall, we observed an obvious distant bystander effect in 92% of the treated rats. Moreover, we clearly established that in an immune -competent animal, the cellular immune response was critical for the development of the distant effect. Several findings support this conclusion: ( a) peritumoral inflammation was consistently observed at the periphery of the untransduced tumors and its intensity correlated with the extent of the tumor regression; ( b) lymphoid cells infiltrating the periphery of the tumors were mainly CD8 + cells; (c ) a Winn assay demonstrated that an antitumor effect was transferred to naive animals via splenocytes obtained from GCV-treated rats, but not with splenocytes from saline-treated animals; (d ) depletion of CD8 + lymphocytes resulted in the complete blunting of the distant bystander effect. However, despite all these concordant evidences for the intervention of the immune system in the establishment of the distant bystander effect, we never observed regression of the Ad -tk ± transduced tumors ( tumor A ) after GCV treatment and survival rate of GCV-treated rats was not significantly different from saline -treated animals.
The distant bystander effect has previously been observed in few models of transplanted tumor cells. 9 ± 11,15 In some studies, tumor A was premixed with 30± 100% tkpositive cells obtained after in vitro retroviral gene transfer before implantation in the animals. In this optimal situation, GCV treatment was, of course, highly efficient on tumor A and a distant bystander effect was also noticed on tumor B but to a much lesser extent. Unfortunately, these situations are not clinically relevant and the distant bystander effect had to be documented in more suitable models. Two studies also described intratumoral delivery of retrovirus via injection in tumor A with recombinant virus producing cells which resulted in partial regression of tumor B. 10, 15 However, a potential spread of the vectors to the distant tumor was not examined and also the level of tumor A transduction was not reported. Here we present the first evidence of a distant bystander effect elicited in vivo after direct injection of a recombinant adenoviral vector. Regression of the distant, nontransduced tumor was dramatic and consistent, often resulting in complete histologic regression. The absence of regression of the injected tumor may be attributed to the low gene transfer efficiency obtained in this model. Indeed, experiments performed with a -galactosidase recombinant adenovirus ( Ad -lacZ ) showed that less than 1% of the tumor cells stained positively for X -Gal after direct injection of the vector into tumor A (data not shown ). The low transduction rate in tumor A might be attributable to the histologic structure of the PROb tumors in which cells grow in close contact to each other, precluding spreading of the viral particles within tumors.
Two explanations may account for the discrepancy between our results and previous studies. First, we used an adenoviral vector, which can be responsible for two apparently contradictory effects. ( a) The adenoviral vector is known to be highly immunogenic. This was shown to be deleterious for direct HSV-tk therapy in a rat mesothelioma model because a better inhibition of tumor growth after Adtk gene transfer and GCV treatment was obtained in immunosuppressed animals as compared to control immunocompetent ones. 16 On the opposite, the immunogenicity of the adenovirus may help in inducing an immune response against the tumor cells, leading to better regression of the untransduced distant tumor. (b ) Secondly, in our model, the untransduced tumor B was implanted 7 days after tumor A. It is, therefore, possible that for unknown reasons, the newly implanted actively growing cells are more susceptible to the distant bystander effect.
We also made an observation which suggests that the distant bystander effect is preferentially loco -regional. Peritoneal carcinosis, which is known to respond to the HSV-tk / GCV approach, 17, 18 was indeed much less frequent control rats depleted rats tumor volume (mm3) tumor B tumor A Figure 9 . Abrogation of the distant bystander effect after CD8 + depletion. Rats were treated with anti -CD8 monoclonal antibody and subjected to the protocol described in Materials and Methods. Animals were sacrificed on day 23 and the volume of tumors A and B measured. Tumor B was absent in control rats, whereas it was found prominent in CD8 + -depleted animals.
Cancer Gene Therapy, Vol 8, No 2, 2001 in the GCV-treated group than in control animals ( 12% vs. 65% ). However, the survival rates did not exhibit a significant difference between GCV-treated and salinetreated animals. The majority of animals died from respiratory distress and had voluminous pulmonary metastasis. The HSV-tk /GCV seemed, therefore, not to be significantly implicated in the antitumoral control of pulmonary metastasis. Kianmanesh et al 9 also reported a more prominent distant bystander effect in tk tumors located in the same liver lobe than those situated in a distinct lobe. Altogether, these observations suggest that the distant bystander effect might actually be either predominant within an organ or restricted to an anatomical region.
The involvement of the immune system in HSV-tk /GCV therapy has been suggested long ago when it was observed that after treatment using this approach, rats were protected against rechallenge with the same tumor. 6 Moreover, it was subsequently demonstrated that the intratumoral bystander effect disappeared in immunocompromised animals. However, conflicting results have been obtained in two studies in which the distant bystander effect was present in immunodeficient mice. Wilson et al 12 reported a distant bystander effect in a model of head and neck squamous cell carcinoma in nude mice. Similarly, Dilber et al 11 reached the same conclusion with plasmocytoma cells in SCID mice. These results strengthened the hypothesis that a cytokine cascade might participate in the establishment of a distant bystander effect. However, a more recent report by Bi et al 10 using tumors of head and neck origin challenged the precedent findings because a distant bystander effect did not occur in SCID mice but was still elicited in nude mice. Older nude mice may develop some functional T lymphocytes which allow the mounting of an incomplete immune response. Although we cannot rule out the possibility that cells other than CD8 + lymphocytes may be implicated in the occurrence of a distant bystander effect, we present strong evidence that these cells are critical at some point in this process by immunohistochemistry phenotyping as well as by antibody-mediated selective CD8 + T-cell depletion. Finally, the ability to transfer an antitumor effect in naive animals after splenocytes transplantation (Winn assay ) further indicates the participation of cellular immunity in the establishment of the distant bystander effect.
The precise mechanism involved in the development of a distant bystander effect remains to be elucidated. In our model, the possibility of vector spreading during tumor A injection is unlikely because the level of transduction in tumor A was low after direct intratumoral injection of AdlacZ. Moreover, there was no detectable spread of the AdlacZ virus either in surrounding normal parenchyma or in distant tumor B (not shown ). We favor the hypothesis that HSV-tk / GCV induced infraclinical lysis of neoplastic cells in tumor A which, in turn, elicited a cellular immune response implicating cytotoxic T cells against a younger, distant tumor B. Indeed, dendritic cells are able to acquire antigens from apoptotic cells and induce cytotoxic immune response. 19 Whether a cytokine cascade is simultaneously activated remains to be explored and our well -characterized model provides a useful tool in that respect. In any case, this clinically relevant gene transfer strategy may help to design new protocols to document and enhance this effect in patients. This is particularly interesting in view of the increasingly complicated relationship between suicide gene therapy and the immune system.
